AR034398A1 - Homologos de 15-hete con 3-heteroatomos sustituidos y dos atomos de carbono del acido hidroxieicosatetraenoico, composicion que los contiene y el uso de la misma para la manufactura de un medicamento - Google Patents

Homologos de 15-hete con 3-heteroatomos sustituidos y dos atomos de carbono del acido hidroxieicosatetraenoico, composicion que los contiene y el uso de la misma para la manufactura de un medicamento

Info

Publication number
AR034398A1
AR034398A1 ARP000105872A ARP000105872A AR034398A1 AR 034398 A1 AR034398 A1 AR 034398A1 AR P000105872 A ARP000105872 A AR P000105872A AR P000105872 A ARP000105872 A AR P000105872A AR 034398 A1 AR034398 A1 AR 034398A1
Authority
AR
Argentina
Prior art keywords
free
functionally modified
pharmaceutically acceptable
same
hete
Prior art date
Application number
ARP000105872A
Other languages
English (en)
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of AR034398A1 publication Critical patent/AR034398A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/60—Unsaturated compounds containing ether groups, groups, groups, or groups the non-carboxylic part of the ether being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se revelan homólogos del 15-hete con 3-heteroátomos sustituidos y dos átomos de carbono del ácido hidroxieicosatetraenoico, que comprenden un compuesto de la fórmula (1), en la cual: R1 es (CH2)n-CO2R, (CH2)nCONR2R3, (CH2)nCH2OR4, (CH2)nCH2NR5R6, (CH2)nCH2N3, (CH2)CH2Hal, (CH2)nCH2NO2, (CH2)nCH2SR20, (CH2)nCOSR21 o (CH2)n-2,3,4,5-tetrazol-1-ilo, en lo cual R representa H, o CO2R forma una sal farmacéuticamente aceptable o un éster farmacéuticamente aceptable; NR2R3 y NR5R6, que son iguales o diferentes, comprenden un grupo amino libre o funcionalmente modificado; OR4 comprende un grupo hidroxi libre o funcionalmente modificado; Hal es F, Cl, Br o I; SR20 comprende un grupo tiol libre o funcionalmente modificado; R21 es H, o COSR21 forma una sal farmacéuticamente aceptable o un tioéster farmacéuticamente aceptable; n vale 0 o 2; X es O, S(O)p, NR7 o CH2, con la condición que X no puede ser CH2 cuando n = 0; p vale 0, 1 o 2; NR7 comprende un grupo amino libre o funcionalmente modificado; A - B, D - E, G - T y J - K, que son iguales o diferentes, son: CH2CH2, CH=CH o C ::: C, con la condición que por lo menos uno de los siguientes: A - B, D - E, G - T y J - K; debe ser CH = CH o C ::: C; e Y es C(O) (es decir, un carbonilo), o Y es fórmula (2) o (3) en lo cual R9O constituye un grupo hidroxi libre o funcionalmente modificado; con la condición que queda excluido el compuesto de la fórmula (4), composición que los contiene y el uso de la misma para la manufactura de un medicamento oftálmico.
ARP000105872A 1999-11-09 2000-11-08 Homologos de 15-hete con 3-heteroatomos sustituidos y dos atomos de carbono del acido hidroxieicosatetraenoico, composicion que los contiene y el uso de la misma para la manufactura de un medicamento AR034398A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16436899P 1999-11-09 1999-11-09

Publications (1)

Publication Number Publication Date
AR034398A1 true AR034398A1 (es) 2004-02-25

Family

ID=22594175

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000105872A AR034398A1 (es) 1999-11-09 2000-11-08 Homologos de 15-hete con 3-heteroatomos sustituidos y dos atomos de carbono del acido hidroxieicosatetraenoico, composicion que los contiene y el uso de la misma para la manufactura de un medicamento

Country Status (12)

Country Link
US (2) US6331644B1 (es)
EP (1) EP1228027B1 (es)
JP (1) JP2003513948A (es)
AR (1) AR034398A1 (es)
AT (1) ATE265996T1 (es)
AU (1) AU776146B2 (es)
CA (1) CA2386333A1 (es)
DE (1) DE60010503T2 (es)
DK (1) DK1228027T3 (es)
ES (1) ES2215740T3 (es)
PT (1) PT1228027E (es)
WO (1) WO2001034548A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1228027E (pt) * 1999-11-09 2004-08-31 Alcon Inc Derivados de 15-hete com heteroatomo substituinte em posicao 3 e homologos com dois carbonos e metodos de utilizacao
JP2005505592A (ja) * 2001-10-11 2005-02-24 アルコン，インコーポレイテッド 抗炎症性ステロイドとｍｕｃ−１分泌促進薬との組み合わせによる、ドライアイを処置するための方法
US20030109508A1 (en) * 2001-10-11 2003-06-12 Alcon, Inc. Methods for treating dry eye
US6831186B2 (en) 2001-11-06 2004-12-14 Schering Aktiengesellschft Lipoxin A4 analogs
EP1583527A1 (en) * 2002-06-14 2005-10-12 Alcon, Inc. Use of hydroxyeicosatetraenoic acid compounds to treat ophthalmic inflammatory disorders
AU2003221707A1 (en) * 2002-06-14 2003-12-31 Alcon, Inc. Topical use of hydroxyeicosatetraenoic acid compounds to treat psoriasis
JP2006502183A (ja) * 2002-09-20 2006-01-19 アルコン，インコーポレイテッド ドライアイ障害の処置のためのサイトカイン合成インヒビターの使用

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991759A (en) 1975-10-28 1976-11-16 Alza Corporation Method and therapeutic system for treating aqueous deficient dry eye
US4131651A (en) 1977-10-25 1978-12-26 Barnes-Hind Pharmaceuticals, Inc. Treatment of dry eye
US4409205A (en) 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
US4370325A (en) 1979-03-30 1983-01-25 Dermik Laboratories Pharmaceutical compositions and method of treatment
AU546872B2 (en) 1982-06-16 1985-09-26 Unilever Plc Skin treatment compositions containing a fatty acid or ester
US4421748A (en) 1982-07-13 1983-12-20 Trager Seymour F Artificial tear aid
GB8319073D0 (en) 1983-07-14 1983-08-17 Efamol Ltd Fatty acid compositions
US4753945A (en) 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
US4868154A (en) 1986-02-19 1989-09-19 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with melanocyte stimulating hormones
US4883658A (en) 1986-04-28 1989-11-28 Holly Frank J Ophthalmic solution for treatment of dry-eye syndrome
US4744980A (en) 1986-04-28 1988-05-17 Holly Frank J Ophthalmic solution for treatment of dry eye syndrome
US4804539A (en) 1986-07-28 1989-02-14 Liposome Technology, Inc. Ophthalmic liposomes
US4818537A (en) 1986-10-21 1989-04-04 Liposome Technology, Inc. Liposome composition for treating dry eye
US4966773A (en) 1986-11-25 1990-10-30 Alcon Laboratories, Inc. Topical ophthalmic compositions containing microfine retinoid particles
US4914088A (en) 1987-04-02 1990-04-03 Thomas Glonek Dry eye treatment solution and method
US5278151A (en) 1987-04-02 1994-01-11 Ocular Research Of Boston, Inc. Dry eye treatment solution
US4921644A (en) 1988-02-29 1990-05-01 Technology Unlimited, Inc. Mucin directed lipsome
US4906467A (en) 1988-03-24 1990-03-06 New York Medical College Novel, long-duration treatment for glaucoma
US4923700A (en) 1988-06-03 1990-05-08 Kaufman Herbert E Artificial tear suspension
US5064655A (en) 1989-02-24 1991-11-12 Liposome Technology, Inc. Liposome gel composition and method
US5075104A (en) 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
US5174988A (en) 1989-07-27 1992-12-29 Scientific Development & Research, Inc. Phospholipid delivery system
AU655919B2 (en) 1990-02-22 1995-01-19 Macnaught Pty Limited Artificial tears
US5041434A (en) 1991-08-17 1991-08-20 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
ZA912797B (en) 1990-05-29 1992-12-30 Boston Ocular Res Dry eye treatment process and solution
ATE132366T1 (de) 1990-05-29 1996-01-15 Boston Ocular Res Zusammensetzung zur behandlung von dry eye erkrankungen
US5102670A (en) 1990-09-14 1992-04-07 Abraham Nader G Method for treating eye disorders by reducing 12(r)-hydroxyeicosatetraenoic acid and 12(r)-dihydroxyeicosatrienoic acid levels
JP2594486B2 (ja) 1991-01-15 1997-03-26 アルコン ラボラトリーズ インコーポレイテッド 局所的眼薬組成物
ZA927277B (en) 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
EP0546728A3 (en) 1991-12-13 1993-09-08 Alcon Laboratories Inc Physiological tear compositions and methods for their preparation
ATE185697T1 (de) 1992-04-21 1999-11-15 Schepens Eye Res Inst Androgentherapie am auge beim sjögrensyndrom
US5290572A (en) 1992-08-06 1994-03-01 Deo Corporation Opthalmic composition for treating dry eye
US5358706A (en) 1992-09-30 1994-10-25 Union Carbide Chemicals & Plastics Technology Corporation Muco-adhesive polymers
US5455265A (en) 1993-02-11 1995-10-03 Allergan, Inc. Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors
DE69419601T2 (de) * 1993-03-17 1999-12-02 Kao Corp., Tokio/Tokyo Aminderivate und sie enthaltende dermatologische zubereitungen
US5389383A (en) 1993-06-18 1995-02-14 Allergan, Inc. Method for treating hypoxia-associated ocular complications
US5696166A (en) * 1995-10-31 1997-12-09 Yanni; John M. Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
SK283518B6 (sk) 1996-10-15 2003-08-05 The Liposome Company, Inc. Konjugát peptidu s lipidom, lipozóm, farmaceutický prostriedok a použitie
US5800807A (en) 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
DE60024594T2 (de) 1999-03-01 2006-08-17 Vista Scientific Llc, Andover Ophthalmologische zubereitung die mucin enthält
PT1228027E (pt) * 1999-11-09 2004-08-31 Alcon Inc Derivados de 15-hete com heteroatomo substituinte em posicao 3 e homologos com dois carbonos e metodos de utilizacao

Also Published As

Publication number Publication date
WO2001034548A2 (en) 2001-05-17
US6331644B1 (en) 2001-12-18
JP2003513948A (ja) 2003-04-15
DK1228027T3 (da) 2004-07-19
CA2386333A1 (en) 2001-05-17
ATE265996T1 (de) 2004-05-15
WO2001034548A3 (en) 2001-11-01
DE60010503D1 (de) 2004-06-09
PT1228027E (pt) 2004-08-31
AU776146B2 (en) 2004-08-26
EP1228027A2 (en) 2002-08-07
AU1101101A (en) 2001-06-06
DE60010503T2 (de) 2004-09-23
EP1228027B1 (en) 2004-05-06
ES2215740T3 (es) 2004-10-16
US20020082286A1 (en) 2002-06-27
US6437160B1 (en) 2002-08-20

Similar Documents

Publication Publication Date Title
CA2414967A1 (en) Valproic acid and derivatives thereof as histone deacetylase inhibitors
NO20071498L (no) Substituerte acylhydroksamsyrer samt fremgangsmate for a redusere TNFa-nivaet
ES2094350T3 (es) Cromano y tiocromanos con sustituyentes de feniletinilo en la posicion 7 que tienen actividad biologica de tipo retinoide.
ATE191143T1 (de) Verwendung von nichtsteroidalen cyclooxygenasehemmern zur herstellung eines medikaments zur behandlung vom erhoehten augeninnendruck
ATE226821T1 (de) Verwendung von langkettigen n-alkyl derivaten von deoxynojirimycin zur herstellung eines medikaments zur behandlung von mit glykolipiden akkumulation zusammenhängenden krankheiten
FI961976A0 (fi) Peptidyyliyhdisteitä ja niiden terapeuttinen käyttö metalloproteinaasien inhibiittoreina
BG92179A (bg) Метод за получаване на 7-заместена-хепт-6-еноена и -хептаноена киселина и техни производни и междинни съединения
BR9713178A (pt) Inbidores espirocìclicos da metaloprotease.
ATE181329T1 (de) Substituierte dibenzooxazepin-verbindungen, pharmazeutische zusammensetzungen und verfahren zur verwendung
CO5140075A1 (es) Agentes terapeuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas
ES2148305T3 (es) Derivados de aminoacidos ciclicos que tienen actividad inhibidora de ace y nep.
DE3586935D1 (de) Hemmungsstoffe enkephalinase-b deren herstellung und deren pharmazeutische zusammensetzungen.
WO1990009993A3 (en) Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
AR034398A1 (es) Homologos de 15-hete con 3-heteroatomos sustituidos y dos atomos de carbono del acido hidroxieicosatetraenoico, composicion que los contiene y el uso de la misma para la manufactura de un medicamento
AU1911999A (en) Methods and compositions for treating diabetes
AR031536A1 (es) Analogos heteroatomo- interrumpidos del acido 15-hidroxieicosatetraenoico, composicion que lo comprende y el uso de los mismos para la manufactura de un medicamento
ES2053668T3 (es) Derivados de poliamina como agentes antineoplasicos.
KR880009934A (ko) 피리딘-2,4-및 2,5-디카복실산 유도체, 이의 제조방법, 이의 용도 및 이들 화합물을 기본으로 하는 약제
DE60231047D1 (de) Verfahren zur unterdrückung oder umkehrung der tau-filament-bildungspolymerisation
NO932843D0 (no) Farmasoeytiske preparater
ES2041815T3 (es) Un procedimiento para la obtencion de derivados de ornitina 5-sustituidos.
BG88028A (bg) Амиди на циклометилен-1,2-дикарбоксилни киселини с терапевтична активност,методи за получаването им и фармацевтични състави, които ги съдържат
ES461785A1 (es) Un metodo para la preparacion de un ester de acido behenico.
OA08881A (fr) Nouveaux tripeptides à structure polycyclique azotée, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
PT92189A (pt) Processo para a preparacao de derivados de difenilacetamidas e de composicoes farmaceuticas que os contem

Legal Events

Date Code Title Description
FB Suspension of granting procedure